Evidence map›Paper›PMID 35948877›Full record

ArticleBMC cancer2022

Inflammatory biomarkers and risk of breast cancer among young women in Latin America: a case-control study.

Emma Fontvieille, Mathilde His, Carine Biessy, Anne-Sophie Navionis, Gabriela Torres-Mejía, Angélica Ángeles-Llerenas, Isabel Alvarado-Cabrero, Gloria Inés Sánchez, Edgar Navarro, Yorlany Rodas Cortes and 11 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 12 institutions in 7 countries.

Emma Fontvieille *International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.
Mathilde His *International Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.
Carine BiessyInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.
Anne-Sophie NavionisInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.
Gabriela Torres-MejíaCentre for Population Health Research, National Institute of Public Health, Cuernavaca, Mexico.
Angélica Ángeles-LlerenasCentre for Population Health Research, National Institute of Public Health, Cuernavaca, Mexico.
Isabel Alvarado-CabreroServicio de Patología, Hospital de Oncología, CMN SXXI, Instituto Mexicano del Seguro Social, Ciudad de México, México.
Gloria Inés SánchezGroup Infection and Cancer, School of Medicine, University of Antioquia, Medellín, Colombia.
Edgar NavarroGrupo Proyecto UNI-Barranquilla, Universidad del Norte, Barranquilla, Colombia.
Yorlany Rodas CortesHemato Oncologos, Cali, Colombia.
Carolina PorrasAgencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San Jose, Costa Rica.
Ana Cecilia RodriguezAgencia Costarricense de Investigaciones Biomédicas (ACIB)-Fundación INCIENSA, San Jose, Costa Rica.
Maria Luisa GarmendiaInstituto de Nutrición y de Tecnología de los Alimentos, Universidad de Chile, Santiago, Chile.
José Luis SotoNational Institute of Cancer, Santiago, Chile.
Leonor MoyanoNational Institute of Cancer, Santiago, Chile.
Peggy L PorterDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, USA.
Ming Gang LinDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, USA.
Jamie GuenthoerDivision of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, USA.
Isabelle RomieuCentre for Population Health Research, National Institute of Public Health, Cuernavaca, Mexico.
Sabina RinaldiInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France. rinaldis@iarc.fr.
PRECAMA team
Fred Hutch Cancer Center · USInstituto Nacional de Salud Pública · MXCentre international de recherche sur le cancer · FRInstituto Costarricense de Investigación y Enseñanza en Nutrición y Salud · CRUniversidad de Antioquia · COInstituto Nacional del Cáncer · CLInstituto de Cancerología Las Américas · COEmory University · USMexican Social Security Institute · MXMunicipality of Medellín · COUniversidad del Norte · COUniversity of Chile · CL

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundBreast cancer incidence is increasing rapidly in Latin America, with a higher proportion of cases among young women than in developed countries. Studies have linked inflammation to breast cancer development, but data is limited in premenopausal women, especially in Latin America.

methodsWe investigated the associations between serum biomarkers of chronic inflammation (interleukin (IL)-6, IL-8, IL-10, tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), leptin, adiponectin) and risk of premenopausal breast cancer among 453 cases and 453 matched, population-based controls from Chile, Colombia, Costa Rica, and Mexico. Odds ratios (OR) were estimated using conditional logistic regression models. Analyses were stratified by size and hormonal receptor status of the tumors.

resultsIL-6 (OR

conclusionsThe results of this study support the implication of chronic inflammation in breast cancer risk in young women in Latin America. Largest studies of prospective design are needed to confirm these findings in premenopausal women.

Indexed as

Breast NeoplasmsBiomarkersCase-Control StudiesFemaleHumansInflammationInterleukin-6Interleukin-8Latin AmericaLeptinRisk FactorsTumor Necrosis Factor-alphaBiomarkersInterleukin-6Interleukin-8LeptinTumor Necrosis Factor-alphaBiomarkersBreast cancerInflammationLatin AmericaPremenopausal

Identifiers

PMID35948877
PMCPMC9367082
OpenAlexW4290987626

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.